Worries about what might happen with the U.S. healthcare system took a toll on the insulin-pump maker's share price.
News & Analysis: Tandem Diabetes Care
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
Medical device stocks were hot in 2018. Here's which ones could sizzle in 2019.
Shares of the insulin pump maker have gained a whopping 1,490% over the last year.
Shares jumped after the company reported blowout fourth-quarter results and issued bullish guidance. Here's what investors need to know.
TNDM earnings call for the period ending December 31, 2018.
Innovative insulin pumps and promising drugs make these three companies worthy of investors' attention.
This insulin pump maker launched a revolutionary new treatment option for type 1 patients.
These healthcare stocks crushed the S&P 500's return last year, but that doesn't guarantee they'll be top performers in 2019.
Shares tumble on a slow news day. What can explain the double-digit move?